Doug Bost became a member of the Scientific Advisory Board for Digital PCR at QIAGEN
Omixon is entering the field of post-transplant monitoring. To ensure its position in the market our company has entered a strategic partnership with Organ Monitoring Group (OMG) founded by Doug Bost to bring our newest product, HoloGRAFT, to market. Doug Bost joined Omixon in the position of VP of...